trial

cTBS on First-episode Drug Naive Patients With Schizophrenia

NCTId NCT05086133
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 44 (actual)
Sponsored by Central South University
Primary completion 2022-11-15
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
44 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2021-11-20
Primary completion
2022-11-15
Eligibility
ALL · 18 Years · 40 Years

Interventions & indications

Drugs
Transcranial Magnetic Stimulation

Sponsors

Central South UniversityLead Sponsor
Shanghai Mental Health CenterCollaborator

Sites

1 total
Changsha, China

Facts & assertions

4 sourced
Enrollment
44
Phase
NA
Primary Completion Date
2022-11-15
Status
UNKNOWN
relationships
The graph out of here
drug
Transcranial Magnetic Stimulation
drug
lead_sponsor
Central South University
company
collaborator
Shanghai Mental Health Center
company
indication
Schizophrenia
indication
Schizophrenia
indication